SEC Form 4 · accession 0001140361-15-019089
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles S. Ryan
Director
Period of report
May 8, 2015
Accepted (ET)
May 12, 2015 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 8, 2015 | P | 200,000 | $0.25 | A | 200,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.75 | May 8, 2015 | P | 50,000 | A | May 8, 2015 | May 8, 2020 | Common Stock | 50,000 | 50,000 | D |
| OptionF1 | $0.40 | holding | — | — | — | — | Apr 6, 2025 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The option vests to the extent of 100,000 shares on each of April 6, 2016, 2017 and 2018